JPWO2021107013A1 - - Google Patents

Info

Publication number
JPWO2021107013A1
JPWO2021107013A1 JP2021561492A JP2021561492A JPWO2021107013A1 JP WO2021107013 A1 JPWO2021107013 A1 JP WO2021107013A1 JP 2021561492 A JP2021561492 A JP 2021561492A JP 2021561492 A JP2021561492 A JP 2021561492A JP WO2021107013 A1 JPWO2021107013 A1 JP WO2021107013A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021561492A
Other languages
Japanese (ja)
Other versions
JP7754490B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021107013A1 publication Critical patent/JPWO2021107013A1/ja
Priority to JP2025113411A priority Critical patent/JP2025143420A/ja
Application granted granted Critical
Publication of JP7754490B2 publication Critical patent/JP7754490B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021561492A 2019-11-29 2020-11-26 アジュバント組成物 Active JP7754490B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025113411A JP2025143420A (ja) 2019-11-29 2025-07-04 アジュバント組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019216835 2019-11-29
JP2019216835 2019-11-29
PCT/JP2020/044027 WO2021107013A1 (ja) 2019-11-29 2020-11-26 アジュバント組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025113411A Division JP2025143420A (ja) 2019-11-29 2025-07-04 アジュバント組成物

Publications (2)

Publication Number Publication Date
JPWO2021107013A1 true JPWO2021107013A1 (https=) 2021-06-03
JP7754490B2 JP7754490B2 (ja) 2025-10-15

Family

ID=76129420

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021561492A Active JP7754490B2 (ja) 2019-11-29 2020-11-26 アジュバント組成物
JP2025113411A Pending JP2025143420A (ja) 2019-11-29 2025-07-04 アジュバント組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025113411A Pending JP2025143420A (ja) 2019-11-29 2025-07-04 アジュバント組成物

Country Status (2)

Country Link
JP (2) JP7754490B2 (https=)
WO (1) WO2021107013A1 (https=)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11512297A (ja) * 1995-09-19 1999-10-26 ファーマダイム・インコーポレイテッド 免疫化または遺伝子療法用の筋肉特異的調節要素を含有してなるｄｎａ構築物
JP2002536339A (ja) * 1999-02-02 2002-10-29 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 細菌毒性におけるｄｎａメチル化の必須な役割に基づいて病原性細菌感染を処置および予防するための組成物および方法
JP2010539918A (ja) * 2007-09-26 2010-12-24 サノフィ・パスツール インフルエンザウイルスの製造方法
JP2012246259A (ja) * 2011-05-30 2012-12-13 Japan Health Science Foundation Ｈ５ｎ１型インフルエンザワクチン及び感染防御キット
US20130011437A1 (en) * 2011-07-05 2013-01-10 Life Spring Immuno Science Corp. Immune compositions for treating H. pylori infection

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11512297A (ja) * 1995-09-19 1999-10-26 ファーマダイム・インコーポレイテッド 免疫化または遺伝子療法用の筋肉特異的調節要素を含有してなるｄｎａ構築物
JP2002536339A (ja) * 1999-02-02 2002-10-29 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 細菌毒性におけるｄｎａメチル化の必須な役割に基づいて病原性細菌感染を処置および予防するための組成物および方法
JP2010539918A (ja) * 2007-09-26 2010-12-24 サノフィ・パスツール インフルエンザウイルスの製造方法
JP2012246259A (ja) * 2011-05-30 2012-12-13 Japan Health Science Foundation Ｈ５ｎ１型インフルエンザワクチン及び感染防御キット
US20130011437A1 (en) * 2011-07-05 2013-01-10 Life Spring Immuno Science Corp. Immune compositions for treating H. pylori infection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
市川文彦ほか: "くすりの解説 マキサカルシトール", ファルマシア, vol. 39, no. 10, JPN6021001360, 2003, pages 967 - 969, ISSN: 0005567502 *

Also Published As

Publication number Publication date
JP2025143420A (ja) 2025-10-01
JP7754490B2 (ja) 2025-10-15
WO2021107013A1 (ja) 2021-06-03

Similar Documents

Publication Publication Date Title
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021017728A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
BR112021017310A2 (https=)
BR112021018484A2 (https=)
BR112021017949A2 (https=)
BR112021018084A2 (https=)
BR112021017983A2 (https=)
BR112021018193A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220524

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231116

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20231116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20231116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250110

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250408

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250704

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250909

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250925

R150 Certificate of patent or registration of utility model

Ref document number: 7754490

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150